Classical and Model-based Estimates of Beta-cell Function During a Mixed Meal Vs. an OGTT in a Population-based Cohort
Overview
Authors
Affiliations
This study compared classical and model-based beta-cell responses during an oral glucose tolerance test (OGTT) and a meal tolerance test (MTT) in a population-based cohort. Individuals with normal glucose metabolism (NGM, n=161), impaired glucose metabolism (IGM, n=19) and type 2 diabetes mellitus (DM, n=20) underwent a 75 g-OGTT and an MTT (75 g carbohydrates, 50 g fat, 24 g proteins). Classical estimates of beta-cell function (insulinogenic index and the ratio of areas under insulin and glucose curves) were calculated. Mathematical modelling was used to determine beta-cell glucose sensitivity, rate sensitivity and potentiation. Insulin sensitivity was characterized by three surrogate estimates. Both classical and model-based estimates of beta-cell function were higher during MTT than during OGTT (P<0.05). Regarding the model-based parameters, especially beta-cell sensitivity was increased following MTT as compared with OGTT (P<0.05). Both during OGTT and MTT, across most parameters describing beta-cell function, the largest reduction in beta-cell response occurred between IGM and DM, while the largest reduction in insulin sensitivity occurred between NGM and IGM. We conclude that beta-cell response is stronger after a mixed meal than after an OGTT with equal carbohydrate quantity, both for classical and model-based parameters. The higher response was mostly explained by higher beta-cell sensitivity during the meal.
Islet hormones at the intersection of glucose and amino acid metabolism.
White P, Wewer Albrechtsen N, Campbell J Nat Rev Endocrinol. 2025; .
PMID: 40055529 DOI: 10.1038/s41574-025-01100-4.
Zelis M, Simonis A, van Dam R, Boomsma D, van Lee L, Kramer M Nutrients. 2024; 16(20).
PMID: 39458507 PMC: 11510361. DOI: 10.3390/nu16203512.
Wrench E, Subar D, Bampouras T, Lauder R, Gaffney C Exp Physiol. 2024; 109(9):1461-1477.
PMID: 39014995 PMC: 11363129. DOI: 10.1113/EP091433.
Bauer I, Rimbach G, Cordeiro S, Bosy-Westphal A, Weghuber J, Ipharraguerre I Front Pharmacol. 2024; 15:1396292.
PMID: 38989154 PMC: 11233739. DOI: 10.3389/fphar.2024.1396292.
Atypical Diabetes: What Have We Learned and What Does the Future Hold?.
Stone S, Balasubramanyam A, Posey J Diabetes Care. 2024; 47(5):770-781.
PMID: 38329838 PMC: 11043229. DOI: 10.2337/dci23-0038.